Member Info for Nolupus

Halfbutt...You are one Brave man to be buying at the moment...BOL with the missus

Tweets are cheap and self serving so don't believe anything other than VERIFIED SOURCES ....

Don't worry, i am never too far away :-)

But all these "rumours" are getting on my nerves....Just waiting on some REAL NEWS ...

For Nomark and Retour du renard .... since when is january in Q2 ??

Extension Study

The Lupuzor open label extension study, initially announced on 18 January 2018, has completed enrolment with a total of 62 eligible patients from the original Phase III trial, who were recruited throughout the US and Europe. The study is anticipated to report results in Q2 2019.

Are you sure about january ??

Nomark, What is due out by the 19 of january ??

Something very fishy fishy....

£ 885 exchanged....Oh hello ?

cunning fox ..are you related to retour du renard ?

Please elaborate, Stockraiser....We are all listening :-)

Where are you ?

Jessell, i think you may have jumped yje gun a bit.....Incanthera have not yet lifted their option and IMM have not yet found a buyer for Ureka....Unless you have priviliged information, of course

And what would that be, jessell ??

A higher risk than IMM ??

Just a 100k quid traded....

lol...you're so funny stew...

Down over 12 % ...BUT small volumes ......Have to keep an eye on the volumes ...so wait and see

Two sides to the coin, easyp...:-)

@halfbutt....I would'nt place a bet on the blue finish :-)

It's good that we can finally agree on something...